No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs569309860 |
chr4:147557368-147557369 |
Inactive region
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs572723190 |
chr4:147557425-147557426 |
Inactive region
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs529075228 |
chr4:147557469-147557470 |
Inactive region
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs111942673 |
chr4:147557479-147557480 |
Inactive region
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs181961526 |
chr4:147557493-147557494 |
Inactive region
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs537551050 |
chr4:147557494-147557495 |
Inactive region
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs374211623 |
chr4:147557525-147557526 |
Inactive region
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs185008160 |
chr4:147557560-147557561 |
Inactive region
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs189874014 |
chr4:147557590-147557591 |
Inactive region
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs557600412 |
chr4:147557643-147557644 |
Inactive region
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs533578227 |
chr4:147557665-147557666 |
Inactive region
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs554022716 |
chr4:147557685-147557686 |
Inactive region
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs376259988 |
chr4:147557697-147557698 |
Inactive region
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs574017868 |
chr4:147557706-147557707 |
Inactive region
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs182984086 |
chr4:147557731-147557732 |
Inactive region
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs556490163 |
chr4:147557747-147557748 |
Inactive region
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs546548263 |
chr4:147557777-147557778 |
Inactive region
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs576435807 |
chr4:147557785-147557786 |
Inactive region
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs545168074 |
chr4:147557803-147557804 |
Bivalent Enhancer
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs564754620 |
chr4:147557851-147557852 |
Bivalent Enhancer
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs150355022 |
chr4:147557866-147557867 |
Bivalent Enhancer
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs116274489 |
chr4:147557867-147557868 |
Bivalent Enhancer
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs543837092 |
chr4:147557880-147557881 |
Bivalent Enhancer
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs370917088 |
chr4:147557911-147557912 |
Bivalent Enhancer
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs188272488 |
chr4:147557913-147557914 |
Bivalent Enhancer
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs191413927 |
chr4:147557944-147557945 |
Bivalent Enhancer
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs183763420 |
chr4:147557946-147557947 |
Bivalent Enhancer
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs563315566 |
chr4:147557948-147557949 |
Bivalent Enhancer
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs11450165 |
chr4:147557949-147557950 |
Bivalent Enhancer
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs146446290 |
chr4:147557983-147557984 |
Bivalent Enhancer
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs568956639 |
chr4:147557995-147557996 |
Bivalent Enhancer
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs531576492 |
chr4:147558007-147558008 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs551176184 |
chr4:147558017-147558018 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs571040128 |
chr4:147558069-147558070 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs6537428 |
chr4:147558072-147558073 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs140944046 |
chr4:147558090-147558091 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs567580431 |
chr4:147558094-147558095 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs144600994 |
chr4:147558098-147558099 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs536548503 |
chr4:147558128-147558129 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs556862489 |
chr4:147558132-147558133 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs188493620 |
chr4:147558158-147558159 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs566577813 |
chr4:147558181-147558182 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs545617917 |
chr4:147558199-147558200 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs1910595 |
chr4:147558237-147558238 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
45 |
rs76832102 |
chr4:147558243-147558244 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs115134269 |
chr4:147558244-147558245 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs561275046 |
chr4:147558280-147558281 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs536706150 |
chr4:147558284-147558285 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs529137398 |
chr4:147558294-147558295 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs542550609 |
chr4:147558332-147558333 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|